Protara Therapeutics, Inc. (TARA) Tops Q2 EPS by 5c

Protara Therapeutics, Inc. (NASDAQ: TARA) reported Q2 EPS of ($0.35), $0.05 better than the analyst estimate of ($0.40).

For earnings history and earnings-related data on Protara Therapeutics, Inc. (TARA) click here.

You May Also Be Interested In

• ATRenew Inc (RERE) Tops Q2 EPS by 8c ; Offers Guidance
• Exyn Technologies, Inc. (EXYN) Reports Q2 Loss of $1.55
• Coty (COTY) Misses Q4 EPS by 1c, offers outlook